Effect of triiodothyronine on adiponectin expression and leptin release by white adipose tissue of normal rats

Hormone and Metabolic Research

Volumn 42, Issue 4, 2010, Pages 254-260

  Cabanelas, A ^a   Cordeiro, A ^a   Santos Almeida, N A Dos ^a   Monteiro De Paula, G S ^a   Coelho, V M ^a   Ortiga Carvalho, T M ^a   Pazos Moura, C C ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Adiponectin; Adipose tissue; Leptin; Thyroid hormones

Indexed keywords

ADIPONECTIN; DEXAMETHASONE; LEPTIN; LIOTHYRONINE; MESSENGER RNA; ROSIGLITAZONE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EPIDIDYMIS FAT; INCUBATION TIME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WHITE ADIPOSE TISSUE;

ADIPONECTIN; ADIPOSE TISSUE, WHITE; ANIMALS; GENE EXPRESSION REGULATION; LEPTIN; MALE; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; TISSUE CULTURE TECHNIQUES; TRIIODOTHYRONINE;

RATTUS; RODENTIA;

EID: 77950483045     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0029-1246118     Document Type: Article

References (63)

1. Ahima RS. Adipose tissue as an endocrine organ. Obesity 2006 14 (Suppl 5) 242S-249S
2. Oetting A, Yen PM. New insights into thyroid hormone action. Best Pract Res Clin Endocrinol Metab 2007 21 193-208
3. Ahima RS, Prabakaran D, Mantzoros C, Qu D, Lowell B, Maratos-Flier E, Flier JS. Role of leptin in the neuroendocrine response to fasting. Nature 1996 382 250-252
4. Légrndi G, Emerson CH, Ahima RS, Flier JS, Lechan RM. Leptin prevents fasting-induced suppression of prothyrotropin-releasing hormone messenger ribonucleic acid in neurons of the hypothalamic paraventricular nucleus. Endocrinology 1997 138 2569-2576
5. Nillni EA, Vaslet C, Harris M, Hollenberg A, Bjrbak C, Flier JS. Leptin regulates prothyrotropin-releasing hormone biosynthesis. Evidence for direct and indirect pathways. J Biol Chem 2000 275 36124-36133
6. Seoane LM, Carro E, Tovar S, Casanueva FF, Dieguez C. Regulation of in vivo TSH secretion by leptin. Reg Pep 2000 92 25-29
7. Harris M, Aschkenasi C, Elias CF, Chandrankunnel A, Nillni EA, Bjorbaek C, Elmquist JK, Flier JS, Hollenberg AN. Transcriptional regulation of the thyrotropin-releasing hormone gene by leptin and melanocortin signaling. J Clin Invest 2001 107 111-120
8. Ortiga-Carvalho TM, Oliveira KJ, Soares BA, Pazos-Moura CC. The role of leptin in the regulation of TSH secretion in the fed state: in vivo and in vitro studies. J Endocrinol 2002 174 121-125
9. Hoyda TD, Samson WK, Ferguson AV. Adiponectin depolarizes parvocellular paraventricular nucleus neurons controlling neuroendocrine and autonomic function. Endocrinology 2009 150 832-840
10. Escobar-Morreale HF, Del Rey FE, Escobar GM. Thyroid hormones influence serum leptin concentrations in the rat. Endocrinology 1997 138 4485-4488
11. Zimmermann-Belsing T, Brabant G, Holst JJ, Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction. Eur J Endocrinol 2003 149 257-271
12. Kokkinos A, Mourouzis I, Kyriaki D, Pantos C, Katsilambros N, Cokkinos DV. Possible implications of leptin, adiponectin and ghrelin in the regulation of energy homeostasis by thyroid hormone. Endocr 2007 32 30-32
13. Medina-Gomes G, Calvo RM, Obregón MJ. T3 and Triac inhibit leptin secretion and expression in brown and white rat adipocytes. Biochim Biophys Acta 2004 1682 38-47
14. Fain JN, Bahouth SW. Effect of tri-iodothyronine on leptin release and leptin nRNA accumulation in rat adipose tissue. Biochem J 1998 332 361-366
15. Arago CN, Souza LL, Cabanelas A, Oliveira KJ, Pazos-Moura CC. Effect of experimental hypo- and hyperthyroidism on serum adiponectin. Metabolism 2007 56 6-11
16. Fujimoto N, Matsuo N, Sumiyoshi H, Yamaguchi K, Saikawa T, Yoshimatsu H, Yoshioka H. Adiponectin is expressed in the brown adipose tissue and surrounding immature tissues in mouse embryos. Biochim Biophys Acta 2005 1731 1-12
17. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Hormonal regulation of adiponectin gene expression in 3T3L1 adipocytes. Biochem Biophys Res Comm 2002 290 1084-1089
18. Corbetta S, Englaro P, Giambona S, Persani L, Blum WF, Beck-Peccoz P. Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur J Endocrinol 1997 37 659-663
19. Sreenan S, Caro JF, Refetoff S. Thyroid dysfunction is not associated with alterations in serum leptin levels. Thyroid 1997 7 407-409
20. Valcavi R, Zini M, Peino R, Casanueva FF, Dieguez C. Influence of thyroid status on serum immunoreactive leptin levels. J Clin Endocrinol Metab 1997 82 1632-1634
21. Leonhardt U, Ritzel U, Schafer G, Becker W, Ramadori G. Serum leptin levels in hypo- and hyperthyroidism. J Endocrinol 1998 157 75-79
22. Wahrenberg H, Wennlund A, Hoffstedt J. Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves' hyperthyroidism. Eur J Endocrinol 2002 146 607-611
23. Pinkney JH, Goodrick SJ, Katz J, Johnson AB, Lightman SL, Coppack SW, Mohamed-Ali V. Leptin and the pituitary-thyroid axis: a comparative study in lean, obese, hypothyroid and hyperthyroid subjects. Clin Endocrinol (Oxf) 1998 49 583-588
24. Matsubara M, Yoshizawa T, Morioka T, Katayose S. Serum leptin and lipids in patients with thyroid dysfunction. J Atheroscler Thromb 2000 7 50-54
25. Iglesias P, Fidalgo PA, Codoceo R, Codoceo R, Díez JJ. Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin Endocrinol (Oxf) 2003 59 621-629
26. Nakamura T, Nagasaka S, Ishikawa S, Hayashi H, Saito T, Kusaka I, Higashiyama M, Saito T. Association of hyperthyroidism with serum leptin levels. Metabolism 2000 49 1285-1288
27. Yoshida T, Momotani N, Hayashi M, Monkawa T, Ito K, Saruta T. Serum leptin concentrations in patients with thyroid disorders. Clin Endocrinol (Oxf) 1998 48 299-302
28. Hsieh CJ, Wang PW, Wang ST, Liu RT, Tung SC, Chien WY, Lu YC, Chen JF, Chen CH, Kuo MC. Serum leptin concentrations of patients with sequential thyroid function changes. Clin Endocrinol (Oxf) 2002 57 29-34
29. Saito T, Kawano T, Saito T, Ikoma A, Namai K, Tamemoto H, Kawakami M, Ishikawa SE. Elevation of serum adiponectin levels in Basedow disease. Metab Clin Experiment 2005 54 1461-1466
30. Yaturu S, Prado S, Grimes SR. Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J Cell Biochem 2004 93 491-496
31. Mineo HA, Oda C, Chiji H, Kawada T, Shimizu K, Taira T. Thiazolidinediones exhibit different effects on preadipocytes isolated from rat mesenteric fat tissue and cell line 3T3-L1 cells derived from mice. Cell Biol Int 2007 31 703-710
32. Phillips SA, Ciaraldi TP, Oh DK, Savu MK, Henry RR. Adiponectin secretion and response to pioglitazone is depot dependent in cultured human adipose tissue. Am J Physiol Endocrinol Metab 2008 295 842-850
33. Fain JN, Buehrer B, Tichansky DS, Madan AK. Regulation of adiponectin release and demonstration of adiponectin mRNA as well as release by the non-fat cells of human omental adipose tissue. Int J Obes 2008 32 429-435
34. Laviola L, Perrini S, Cignarelli A, Natalicchio A, Leonardini A, De Stefano F, Cuscito M, De Fazio M, Memeo V, Neri V, Cignarelli M, Giorgino R, Giorgino F. Insulin signaling in human visceral and subcutaneous adipose tissue in vivo. Diabetes 2006 55 952-961
35. Lefebvre AM, Laville M, Vega N, Riou JP, van Gaal L, Auwerx J, Vidal H. Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 1998 47 98-103
36. Vab Harmelen V, Reynisdottir S, Eriksson P, Thrne A, Hoffstedt J, Lnnqvist F, Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 1998 47 913-917
37. Fain JN, Madan AK, Hiler ML, Cheema P, Bahouth SW. Comparison of the release of adipokines by adipose tissue, adipose tissue matrix, and adipocytes from visceral and subcutaneous abdominal adipose tissues of obese humans. Endocrinology 2004 145 2273-2282
38. Motoshima H, Wu X, Sinha MK, Hardy VE, Rosato EL, Barbot DJ, Rosato FE, Goldstein BJ. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 2002 87 5662-5667
39. Delporte ML, Funahashi T, Takahashi M, Matsuzawa Y, Brichard SM. Pre- and post-translational negative effect of beta-adrenoceptor agonist on adiponectin secretion: in vitro and in vivo studies. Biochem J 2002 367 677-685
40. Altomonte J, Harbaran S, Richter A, Dong H. Fat depot-specific expression of adiponectin is impaired in Zucker fatty rats. Metabolism 2003 52 958-963
41. Atzmon G, Yang XM, Muzumdar R, Ma XH, Gabriely I, Barzilai N. Differential Gene Expression Between Visceral and Subcutaneous Fat Depots. Horm Metab Res 2002 34 622-628
42. Oliver P, Picó C, Palou A. Ontogenesis of leptin expression in different adiposetissue depots in the rat. Pflgers Arch Eur J Physiol 2001 442 383-390
43. Wajchenberg B L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000 21 697-738
44. Samuels HH, Stanley F, Casanova J. Depletion of L-3,5,3-triiodothyronine and l-thyroxine in euthyroid calf serum for use in cell culture studies of action of thyroid hormone. Endocrinology 1979 105 80-85
45. Machado DS, Sabeta A, Santiago LA, Sidhaye AR, Chiamolera MI, Ortiga-Carvalho TM, Wondisford FE. A thyroid hormone receptor mutation that dissociates thyroid hormone regulation of gene expression in vivo. Proc Natl Acad Sci U S A 2009 106 9441-9446
46. Yoda M, Nakano Y, Tobe T, Shioda S, Choi-Miura NH, Tomita M. Characterization of mouse GBP28 and its induction by exposure to cold. Int J Obes 2001 25 75-83
47. Quinn CE, Hamilton PK, Lockhart CJ, McVeigh GE. Thiazolidinediones: effects on insulin resistance and the cardiovascular system. Brit J Pharmacol 2008 153 636-645
48. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y. PPAR ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 2094-2099
49. Iwaki M, Matsuda M, Maeda N, Funahashi T, Matsuzawa Y, Makishima M, Shimomura I. Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003 52 1655-1663
50. Pajvani UB, Hawkins M, Combs TP, Rajala MW, Doebber T, Berger JP, Wagner JA, Wu M, Knopps A, Xiang AH, Utzschneider KM, Kahn SE, Olefsky JM, Buchanan TA, Scherer PE. Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulinsensitivity. J Biol Chem 2004 279 12152-12162
51. Tonelli J, Li W, Kishore P, Pajvani UB, Kwon E, Weaver C, Scherer PE, Hawkins M. Mechanisms of early insulin-sensitizing effects of thiazolidinediones in Type 2 Diabetes. Diabetes 2004 53 1621-1629
52. Nawrocki AR, Rajala MW, Tomas E, Pajvani UB, Saha AK, Trumbauer ME, Pang Z, Chen AS, Ruderman NB, Chen H, Rossetti L, Scherer PE. Mice lacking adiponectin show decreased hepatic insulin sensitivity and reduced responsiveness to peroxisome proliferator-activated receptor agonists. J Biol Chem 2006 281 2654-2660
53. Viengchareun S, Zennaro MC, Lê Tallec LP. Brown adipocytes are novel sites of expression and regulation of adiponectin and resistin. Fed Eur Biochem Soc Lett 2002 532 345-350
54. Rasouli N, Yao-Borengasser A, Miles LM, Elbein SC, Kern PA. Increased plasma adiponectin in response to pioglitazone does not result from increased gene expression. Am J Physiol Endocrinol Metab 2006 290 E42-E46
55. Combs TP, Wagner JA, Berger J, Doebber T, Wang WJ, Zhang BB, Tanen M, Berg AH, O'Rahilly S, Savage DB, Chatterjee K, Weiss S, Larson PJ, Gottesdiener KM, Gertz BJ, Charron MJ, Scherer PE, Moller DE. Induction of adipocyte complement-related protein of 30 kilodaltons by PPARgamma agonists: a potential mechanism of insulin sensitization. Endocrinology 2002 143 998-1007
56. Inokuchi T, Tsutsumi Z, Takahashi S, Ka T, Yamamoto A, Moriwaki Y, Masuzaki H, Yamamoto T. Effects of benzbromarone and allopurinol on adiponectin in vivo and in vitro. Horm Metab Res 2009 41 327-332
57. Klimcakova E, Moro C, Mazzucotelli A, Lolmde K, Viguerie N, Galitzky J, Stich V, Langin D. Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists. Biochem Bioph Res Comm 2007 358 897-902
58. De Vos P, Saladin R, Auwerx J, Staels B. Induction of ob gene expression by corticosteroids is accompanied by body weight loss and reduced food intake. J Biol Chem 1995 270 15958-15961
59. Murakami T, Iida M, Shima K. Dexamethasone regulates obese expression in isolated rat adipocytes. Biochem Biophys Res Comm 1995 214 126-127
60. Slieker LJ, Sloop KW, Surface PL, Kriauciunas A, LaQuier F, Manetta J, Bue-Valleskey J, Stephens TW. Regulation of ob mRNA and protein by glucocorticoids and cAMP. J Biol Chem 1996 271 5301-5304
61. Halleux CM, Takahashi M, Delporte ML, Detry R, Funahashi T, Matsuzawa Y, Brichard SM. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Comm 2001 288 1102-1107
62. Degawa-Yamauchi M, Moss KA, Bovenkerk JE, Shankar SS, Morrison CL, Lelliott CJ, Vidal-Puig A, Jones R, Considine RV. Regulation of Adiponectin expression in human adipocytes: effect of adiposity, glucocorticoids, and tumor necrosis factor alpha. Obes Res 2005 13 662-669
63. Patel JV, Cummings DE, Girod JP, Mascarenhas AV, Hughes EA, Gupta M, Lip GY, Reddy S, Brotman DJ. Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment. J Negat Results Biomed 2006 11 14